Published in J Cancer Res Clin Oncol on January 01, 1987
Synaptophysin: molecular organization and mRNA expression as determined from cloned cDNA. EMBO J (1987) 1.93
Nuclear A-type lamins are differentially expressed in human lung cancer subtypes. Am J Pathol (1993) 1.27
Expression of the proto-oncogenes c-met and c-kit and their ligands, hepatocyte growth factor/scatter factor and stem cell factor, in SCLC cell lines and xenografts. Br J Cancer (1993) 1.10
The expression of the platelet-derived and transforming growth factor genes in human nonsmall lung cancer cell lines is related to tumor stroma formation in nude mice tumors. Am J Pathol (1988) 0.95
Differential expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human lung carcinoma cell lines. Br J Cancer (1993) 0.90
Paclitaxel and TRAIL synergize to kill paclitaxel-resistant small cell lung cancer cells through a caspase-independent mechanism mediated through AIF. Anticancer Res (2011) 0.89
Small cell lung cancer cells express the late stage gBK tumor antigen: a possible immunotarget for the terminal disease. Am J Transl Res (2014) 0.88
In vitro invasion of small-cell lung cancer cell lines correlates with expression of epidermal growth factor receptor. Br J Cancer (1998) 0.87
Differential cytotoxicity of 19 anticancer agents in wild type and etoposide resistant small cell lung cancer cell lines. Br J Cancer (1993) 0.85
Expression of transforming growth factor beta (TGF beta) receptors and expression of TGF beta 1, TGF beta 2 and TGF beta 3 in human small cell lung cancer cell lines. Br J Cancer (1993) 0.84
Expression of histidine decarboxylase and synthesis of histamine by human small cell lung carcinoma. Am J Pathol (2002) 0.84
The effect of bioequivalent radiation dose on survival of patients with limited-stage small-cell lung cancer. Radiat Oncol (2011) 0.83
Prevalence and characterization of murine leukemia virus contamination in human cell lines. PLoS One (2015) 0.76
Distinction of two different classes of small-cell lung cancer cell lines by enzymatically inactive neuron-specific enolase. Br J Cancer (1992) 0.75
Immunotargeting of human small cell lung cancer xenografts in athymic mice using a monoclonal antibody (RNL-1) against a neuroendocrine-related antigen. Br J Cancer Suppl (1991) 0.75
Three types of human lung tumour cell lines can be distinguished according to surface expression of endogenous urokinase and their capacity to bind exogenous urokinase. Br J Cancer (1992) 0.75
Changes in tumor-antigen expression profile as human small-cell lung cancers progress. Cancer Biol Med (2015) 0.75
Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res (1985) 5.02
Screening for lung cancer. N Engl J Med (2000) 3.85
Severe lymphocytopenia and interstitial pneumonia in patients treated with paclitaxel and simultaneous radiotherapy for non-small-cell lung cancer. J Clin Oncol (1996) 1.73
Endothelial-like cells derived from human CD14 positive monocytes. Differentiation (2000) 1.73
Isolation of elastase-like and chymotrypsin-like neutral proteases from human granulocytes. Hoppe Seylers Z Physiol Chem (1974) 1.62
Contiguous pattern spreading in patients with Hodgkin's disease. Radiother Oncol (1998) 1.55
[MRI with supermagnetic iron particles versus double-spiral CT in identification of malignant liver lesions]. Rofo (1998) 1.51
Hot spots for molecular genetic alterations in lung cancer. In Vivo (1999) 1.49
Management and outcomes of haemorrhage after pancreatogastrostomy versus pancreatojejunostomy. Br J Surg (2011) 1.46
What can interest tell us about uptake of genetic testing? Intention and behavior amongst smokers related to patients with lung cancer. Public Health Genomics (2009) 1.45
Results of a double-blind, randomized study to evaluate the efficacy and safety of Antibiophilus in patients with radiation-induced diarrhoea. Eur J Gastroenterol Hepatol (2001) 1.44
Kinetics of pulmonary leukocyte sequestration in man during hemodialysis with different membrane-types. Int J Artif Organs (1990) 1.40
[Adjuvant therapy in colonic carcinoma]. Dtsch Med Wochenschr (1991) 1.39
[Stomal metastases after translaryngeal tracheotomy (TLT) according to Fantoni: a rare complication]. HNO (2007) 1.39
[Intensive medical treatment of severe malaria tropica]. Dtsch Med Wochenschr (1991) 1.39
[The value of radioimmunoscintigraphy compared to computed tomography in the diagnosis and relapse diagnosis of colorectal tumors]. Rofo (1992) 1.38
Long term results of unicondylar fractures of the femur. J Orthop Trauma (1994) 1.37
Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma. Oncogene (2009) 1.37
Ectopic hormones in lung cancer patients at diagnosis and during therapy. Cancer (1980) 1.29
A functional toll-like receptor 8 variant is associated with HIV disease restriction. J Infect Dis (2008) 1.29
MCM2 is an independent predictor of survival in patients with non-small-cell lung cancer. J Clin Oncol (2001) 1.21
Studies in chronic lymphocytic leukemia: further studies of the proliferative abnormality of the blood lymphocyte. Blood (1969) 1.17
Demonstration of granulocytic proteases in plasma of patients with acute leukemia and septicemia with coagulation defects. Blood (1977) 1.16
Analysis of prognostic factors in 766 patients with small cell lung cancer (SCLC): the role of sex as a predictor for survival. Br J Cancer (1991) 1.16
Effects of luting agent and thermocycling on bond strengths to root canal dentine. Int Endod J (2006) 1.15
[Cryo-ultramicrotomy as a rapid method for electron microscopy]. Mikroskopie (1973) 1.15
Characterization of the state of differentiation of six newly established human non-small-cell lung cancer cell lines. Differentiation (1988) 1.15
Epidermal growth factor receptor expression in human lung cancer cell lines. Cancer Res (1988) 1.14
MCM2--a promising marker for premalignant lesions of the lung: a cohort study. BMC Cancer (2001) 1.14
The delayed response of c0ronic lymphocytic leukemia lymphocytes to phytohemagglutinin in vitro. Proc Soc Exp Biol Med (1968) 1.14
Steroid-hormone receptors in cell lines and tumor biopsies of human lung cancer. Int J Cancer (1996) 1.13
Expression and function of VLA-alpha 2, -alpha 3, -alpha 5 and -alpha 6-integrin receptors in pancreatic carcinoma. Int J Cancer (1992) 1.13
Physiology and pathophysiology of neutral proteinases of human granulocytes. Adv Exp Med Biol (1984) 1.12
Growth-inhibitory effects of vitamin D analogues and retinoids on human pancreatic cancer cells. Br J Cancer (1996) 1.10
Dendritic cells derived from peripheral monocytes express endothelial markers and in the presence of angiogenic growth factors differentiate into endothelial-like cells. Eur J Cell Biol (2001) 1.10
The McRoberts' maneuver for the alleviation of shoulder dystocia: how successful is it? Am J Obstet Gynecol (1997) 1.09
Ex vivo study on root canal instrumentation of two rotary nickel-titanium systems in comparison to stainless steel hand instruments. Int Endod J (2009) 1.08
Primary osteosarcoma of the breast--case report and review of the literature. Acta Oncol (1994) 1.06
Expression of insulin-like growth factor receptors I and II in normal human lung and in lung cancer. J Cancer Res Clin Oncol (1993) 1.06
Chlororganic pesticides and polychlorinated biphenyls in breast tissue of women with benign and malignant breast disease. Arch Environ Contam Toxicol (1998) 1.05
Chemokine profile of synovial fluid from normal, osteoarthritis and rheumatoid arthritis patients: CCL25, CXCL10 and XCL1 recruit human subchondral mesenchymal progenitor cells. Osteoarthritis Cartilage (2010) 1.05
Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial. J Clin Oncol (1987) 1.05
Instructive induction of prostate growth and differentiation by a defined urogenital sinus mesenchyme. Microsc Res Tech (1995) 1.04
A PDZ domain protein interacts with the C-terminal tail of the insulin-like growth factor-1 receptor but not with the insulin receptor. J Biol Chem (2001) 1.04
Degradation products of fibrinogen by elastase-like neutral protease from human granulocytes. Characterization and effects on blood coagulation in vitro. J Clin Invest (1978) 1.03
Influence of different volume therapies and pentoxifylline infusion on circulating soluble adhesion molecules in critically ill patients. Crit Care Med (1996) 1.03
Maximizing the motivational impact of feedback of lung cancer susceptibility on smokers' desire to quit. J Health Commun (2000) 1.03
The exocytosis of human blood platelets. A fast freezing and freeze-substitution analysis. Eur J Cell Biol (1987) 1.02
Multicentre randomized therapeutic trial for advanced centrocytic lymphoma: anthracycline does not improve the prognosis. Hematol Oncol (1989) 1.02
Association of TLR7 single nucleotide polymorphisms with chronic HCV-infection and response to interferon-a-based therapy. J Viral Hepat (2008) 1.02
Expression of bcl-2--protein in small cell lung cancer. Lung Cancer (1996) 1.02
DAZ (Deleted in AZoospermia) genes encode proteins located in human late spermatids and in sperm tails. Hum Reprod (1998) 1.01
[Phytohemagglutinin (PHA) and serum proteins in lymphocyte culture. I. Demonstration of promotor and inhibitory serum factors]. Z Gesamte Exp Med (1970) 1.01
Human mastoid periosteum-derived stem cells: promising candidates for skeletal tissue engineering. J Tissue Eng Regen Med (2008) 1.01
The heart: a target organ for estradiol. Science (1977) 1.01
Proteolytic cleavage of human IgG molecules by neutral proteases of polymorphonuclear leukocytes. Eur J Immunol (1978) 1.00
Drug monitoring of etoposide (VP16-213). Correlation of pharmacokinetic parameters to clinical and biochemical data from patients receiving etoposide. Cancer Chemother Pharmacol (1987) 0.99
Successful treatment of clozapine induced agranulocytosis with granulocyte-colony stimulating factor (G-CSF). Br J Haematol (1992) 0.99
Nuclear localization of insulin-like growth factor binding protein 3 in a lung cancer cell line. Endocrinology (1997) 0.98
Differential expression and biological activity of the heparin-binding growth-associated molecule (HB-GAM) in lung cancer cell lines. Int J Cancer (1997) 0.97
Effect of elastase-like and chymotrypsin-like neutral proteases from human granulocytes on isolated clotting factors. Thromb Res (1975) 0.97
[Injuries of the proximal tibial epiphysis]. Unfallchirurg (1987) 0.96
[Fine structure of dystrophic hairs following Vitamin A and thallium intoxication]. Hautarzt (1972) 0.96
Carcinoembryonic antigen and ferritin in patients with lung cancer before and during therapy. Cancer (1978) 0.96
Establishment of rat endometrial cell lines by retroviral mediated transfer of immortalizing and transforming oncogenes. Oncogene (1990) 0.95
Intraglandular application of botulinum toxin leads to structural and functional changes in rat acinar cells. Br J Pharmacol (2007) 0.94
Enhanced serotonergic responsivity following electroconvulsive therapy in patients with major depression. Br J Psychiatry (1992) 0.93
Clinical, radiological and histological findings in desmoplastic infantile ganglioglioma. Childs Nerv Syst (1994) 0.93
Immunocytochemical localization of human 5 alpha-reductase 2 with polyclonal antibodies in androgen target and non-target human tissues. J Histochem Cytochem (1994) 0.93
Lung cancer and the human gene for ribonucleotide reductase subunit M1 (RRM1). Mamm Genome (1999) 0.93
Expression of antimicrobial peptides in cutaneous infections after skin surgery. Br J Dermatol (2010) 0.93
Studies toward the biomimetic synthesis of tropolone natural products via a hetero Diels-Alder reaction. Org Lett (1999) 0.93
Sonographic patterns of the affected spleen in malignant lymphoma. J Clin Ultrasound (1990) 0.93
Androgen receptors, androgen-dependent proliferation, and 5 alpha-reductase activity of small-cell lung cancer cell lines. Int J Cancer (1989) 0.93
The disturbance of hemostasis in septic shock: role of neutrophil elastase and thrombin, effects of antithrombin III and plasma substitution. Eur J Haematol (1989) 0.93
Localisation of hyaluronate (HA) in primary tumors and nude mouse xenografts of human pancreatic carcinomas using a biotinylated HA-binding protein. Virchows Arch (1994) 0.92
Expression and potential role of E-cadherin in pancreatic carcinoma. Int J Pancreatol (1996) 0.92
Selective inhibition of human lung cancer cell growth by peptides derived from retinoblastoma protein. Biochem Biophys Res Commun (2000) 0.92
Prognostic significance of nucleolar organizing regions (NORs) in carcinomas of the sigmoid colon and rectum. Pathol Res Pract (1990) 0.92
[Correlation of alpha-2 pregnancy associated glycoprotein with the clinical course of bronchial carcinoma (author's transl)]. Thoraxchir Vask Chir (1977) 0.92
Bronchial reactivity in hyperresponsive patients and healthy individuals: demonstration with high resolution computed tomography. Eur J Radiol (2004) 0.92
Experimental studies of the biology of human small cell lung cancer. Cancer Treat Rep (1983) 0.92
[Acetone compression. A fast, standardized method to investigate gastrointestinal lymph nodes]. Pathologe (2010) 0.92
Smoking and in vitro fertilization: a meta-analysis. J Assist Reprod Genet (1997) 0.92
Protease activity as a possible mechanism of migration inhibitory factor. Eur J Immunol (1972) 0.91
Fibronectin in human prostatic cells in vivo and in vitro: expression, distribution, and pathological significance. Histochem Cell Biol (1999) 0.91
Pharmacokinetics of etoposide: correlation of pharmacokinetic parameters with clinical conditions. Cancer Chemother Pharmacol (1993) 0.91
In situ protein expression of RRM1, ERCC1, and BRCA1 in metastatic breast cancer patients treated with gemcitabine-based chemotherapy. Cancer Invest (2010) 0.91
Granulocyte colony-stimulating factor prophylaxis before operation protects against lethal consequences of postoperative peritonitis. Surgery (1994) 0.90
Markers and characteristics of human SCLC cell lines. Neuroendocrine markers, classical tumor markers, and chromosomal characteristics of permanent human small cell lung cancer cell lines. J Cancer Res Clin Oncol (1987) 0.90
NCAM: a surface marker for human small cell lung cancer cells. FEBS Lett (1990) 0.90